![Mayo Clinic Cardiovascular CME artwork](https://is3-ssl.mzstatic.com/image/thumb/PodcastSource125/v4/8c/31/07/8c3107f8-eb2a-fed4-07e9-e7852339da02/36568b51-8c5e-46c3-b39b-cb867b773712.jpg/100x100bb.jpg)
Cardiac Involvement in COVID-19
Mayo Clinic Cardiovascular CME
English - August 03, 2021 11:00 - 10 minutes - 23.1 MBEducation Health & Fitness Medicine Homepage Download Apple Podcasts Google Podcasts Overcast Castro Pocket Casts RSS feed
Cardiac Involvement in COVID-19
Guest: Patricia A. Pellikka, M.D. (@pattypellikka)
Host: Paul A. Friedman, M.D. (@drpaulfriedman)
Early reports from Wuhan, China, noted that patients with underlying cardiovascular disease had a higher risk of morbidity and mortality if they contracted the COVID-19 virus. More recently, data support that patients with evidence of cardiac disease during their COVID-19 episodes also have higher rates of morbidity and mortality during hospitalization for treatment of COVID-19.
Joining us today to discuss the cardiac involvement in patients with COVID-19 is Patricia A. Pellikka, M.D., vice chair of Cardiovascular Medicine at Mayo Clinic in Rochester, Minnesota.
Specific topics discussed:
Significance of cardiac involvement in patients with COVID-19
Diagnosis of cardiac dysfunction in patients with COVID-19
Myocarditis and other cardiac injury in patients with COVID-19
Implications of MRI-identified myocarditis
COVID-19 long-haulers and cardiac evaluation
Artificial intelligence in electrocardiogram or echocardiogram
Connect with Mayo Clinic's Cardiovascular Continuing Medical Education online at https://cveducation.mayo.edu or on Twitter @MayoClinicCV.
No CME credit offered for this episode.
Podcast episode transcript here.